Chargement en cours...
Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial
AIMS: The SHIFT trial showed that ivabradine reduced heart rate (HR) and the risk of cardiovascular outcomes. Concerns remain over the efficacy and safety of ivabradine on heart failure (HF) due to Chagas disease (ChD). We therefore conducted a post hoc analysis of the SHIFT trial to investigate the...
Enregistré dans:
| Publié dans: | ESC Heart Fail |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933959/ https://ncbi.nlm.nih.gov/pubmed/29266804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12240 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|